CN Patent

CN119112906A — 用于治疗癫痫性紊乱的方法和组合物

Assigned to Ovid Therapeutics Inc · Expires 2024-12-13 · 1y expired

What this patent protects

本申请涉及用于治疗癫痫性紊乱的方法和组合物。变构调节剂和/或加波沙朵(gaboxadol)用于治疗有相应需要的受试者中的癫痫性紊乱的用途。

USPTO Abstract

本申请涉及用于治疗癫痫性紊乱的方法和组合物。变构调节剂和/或加波沙朵(gaboxadol)用于治疗有相应需要的受试者中的癫痫性紊乱的用途。

Drugs covered by this patent

Patent Metadata

Patent number
CN119112906A
Jurisdiction
CN
Classification
—
Expires
2024-12-13
Drug substance claim
No
Drug product claim
No
Assignee
Ovid Therapeutics Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.